lovastatin has been researched along with Blood Clot in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chien, CT; Chueh, TH; Hsia, CP; Tien, AJ | 1 |
Karnicki, K; McBane, RD; Obi, C; Owen, WG; Wysokinski, W | 1 |
Dong, J; Fujii, S; Furumoto, T; Goto, D; Imagawa, S; Kitabatake, A; Li, H; Nakabayashi, H; Nishi, S; Sakai, M; Zaman, TA | 1 |
Gurbanov, E; Shiliang, X | 1 |
Currier, JW; Faxon, DP | 1 |
Grau, E; Pastor, E; Perella, M | 1 |
Rosenson, RS; Tangney, CC | 1 |
Sinzinger, H | 1 |
Farmer, JA; Gotto, AM | 1 |
5 review(s) available for lovastatin and Blood Clot
Article | Year |
---|---|
The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.
Topics: Apoptosis; Dichloroacetic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Lovastatin; MAP Kinase Kinase Kinase 5; Microtubule-Associated Proteins; Muscle, Smooth, Vascular; Neoplasm Proteins; Pancreatic Elastase; PPAR gamma; Protein Serine-Threonine Kinases; Pulmonary Circulation; Receptor, Bradykinin B2; rho-Associated Kinases; Simvastatin; Survivin; Thrombosis; Vasoconstriction | 2006 |
Prevention of post-PTCA restenosis.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Blood Platelets; Calcium; Colchicine; Fish Oils; Humans; Lovastatin; Molsidomine; Oligopeptides; Peptides, Cyclic; Recurrence; Somatostatin; Steroids; Thrombosis | 1995 |
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
Topics: Animals; Antithrombins; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Endothelium, Vascular; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation; Lovastatin; Muscle, Smooth, Vascular; Platelet Aggregation; Pravastatin; Simvastatin; Thromboplastin; Thrombosis | 1998 |
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibrinolysis; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Niacin; Pravastatin; Risk Factors; Simvastatin; Thrombosis | 1998 |
Pleiotropic effects of statins: do they matter?
Topics: Animals; Cardiovascular Diseases; Cholesterol, LDL; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lovastatin; Thrombosis | 2001 |
1 trial(s) available for lovastatin and Blood Clot
Article | Year |
---|---|
Prevention of post-PTCA restenosis.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Blood Platelets; Calcium; Colchicine; Fish Oils; Humans; Lovastatin; Molsidomine; Oligopeptides; Peptides, Cyclic; Recurrence; Somatostatin; Steroids; Thrombosis | 1995 |
4 other study(ies) available for lovastatin and Blood Clot
Article | Year |
---|---|
Monascus Adlay and Monacolin K Attenuates Arterial Thrombosis in Rats through the Inhibition of ICAM-1 and Oxidative Stress.
Topics: Animals; Carotid Arteries; Chlorides; Ferric Compounds; Intercellular Adhesion Molecule-1; Lovastatin; Monascus; Oxidative Stress; Plant Extracts; Rats; Thrombosis | 2016 |
Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy.
Topics: Animals; Blood Platelets; Carotid Artery Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intravenous; Lovastatin; Organelles; Platelet Activation; Swine; Thrombosis; Time Factors | 2009 |
Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
Topics: Animals; Atherosclerosis; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Protein-delta; Cell Line, Tumor; Cell Nucleus; Chromosome Mapping; Gene Expression; Hepatocytes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Liver Neoplasms; Lovastatin; Mice; Mice, Inbred ICR; Mutagenesis, Site-Directed; Plasminogen Activator Inhibitor 1; Promoter Regions, Genetic; Response Elements; RNA, Messenger; Thrombosis; Transfection | 2005 |
Simvastatin-oral anticoagulant interaction.
Topics: Acenocoumarol; Aged; Anticholesteremic Agents; Anticoagulants; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Simvastatin; Thrombosis | 1996 |